The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies

Journal of Autoimmunity

Volumn 35, Issue 3, 2010, Pages 265-268

  Tsuda, Masanobu ^a   Torgerson, Troy R ^b   Selmi, Carlo ^a,c   Gambineri, Eleonora ^d   Carneiro Sampaio, Magda ^e   Mannurita, Sara Ciullini ^d   Leung, Patrick S C ^a   Norman, Gary L ^f   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f INOVA DIAGNOSTICS INC   (United States)

Author keywords

Autoantibodies; Autoimmune cholangitis; Pediatrics; X chromosome

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA; MITOCHONDRION ANTIBODY;

ADOLESCENT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; INFANT; IPEX SYNDROME; MALE; NEWBORN; PRESCHOOL CHILD; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD;

ADOLESCENT; ANTIGENS, CD4; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, X; DNA MUTATIONAL ANALYSIS; ECZEMA; EPITOPES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER CIRRHOSIS, BILIARY; MALE; MUTATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; T-LYMPHOCYTES, REGULATORY;

EID: 77957782111     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.06.017     Document Type: Article

References (43)

1. Ochs H.D., Gambineri E., Torgerson T.R. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 2007, 38:112-121.
2. Morris G.P., Brown N.K., Kong Y.C. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun 2009, 33:68-76.
3. Moraes-Vasconcelos D., Costa-Carvalho B.T., Torgerson T.R., Ochs H.D. Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. J Clin Immunol 2008, 28(Suppl 1):S11-S19.
4. Myers A.K., Perroni L., Costigan C., Reardon W. Clinical and molecular findings in IPEX syndrome. Arch Dis Child 2006, 91:63-64.
5. McGinness J.L., Bivens M.M., Greer K.E., Patterson J.W., Saulsbury F.T. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol 2006, 55:143-148.
6. Mattalia A., Quaranta S., Leung P.S., Bauducci M., Van de Water J., Calvo P.L., et al. Characterization of antimitochondrial antibodies in health adults. Hepatology 1998, 27:656-661.
7. Oertelt S., Rieger R., Selmi C., Invernizzi P., Ansari A.A., Coppel R.L., et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007, 45:659-665.
8. Selmi C., Zuin M., Bowlus C.L., Gershwin M.E. Anti-mitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis 2008, 12:173-185. ix.
9. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
10. Bussone G., Mouthon L. Autoimmune manifestations in primary immune deficiencies. Autoimmun Rev 2009, 8:332-336.
11. Bindl L., Torgerson T., Perroni L., Youssef N., Ochs H.D., Goulet O., et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J Pediatr 2005, 147:256-259.
12. Rao A., Kamani N., Filipovich A., Lee S.M., Davies S.M., Dalal J., et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 2007, 109:383-385.
13. Kobayashi I., Shiari R., Yamada M., Kawamura N., Okano M., Yara A., et al. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J Med Genet 2001, 38:874-876.
14. Huter E.N., Natarajan K., Torgerson T.R., Glass D.D., Shevach E.M. Autoantibodies in scurfy mice and IPEX patients recognize keratin 14. J Invest Dermatol 2010, 130:1391-1399.
15. Gambineri E., Perroni L., Passerini L., Bianchi L., Doglioni C., Meschi F., et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol 2008, 122:1105-1112. e1.
16. Barak V., Selmi C., Schlesinger M., Blank M., Agmon-Levin N., Kalickman I., et al. Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. J Autoimmun 2009.
17. Selmi C., Zuin M., Gershwin M.E. The unfinished business of primary biliary cirrhosis. J Hepatol 2008, 49:451-460.
18. Shimoda S., Miyakawa H., Nakamura M., Ishibashi H., Kikuchi K., Kita H., et al. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 2008, 31:110-115.
19. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 2008, 7:626-630.
20. Dahlan Y., Smith L., Simmonds D., Jewell L.D., Wanless I., Heathcote E.J., et al. Pediatric-onset primary biliary cirrhosis. Gastroenterology 2003, 125:1476-1479.
21. Selmi C., Invernizzi P., Zuin M., Podda M., Gershwin M.E. Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology. Semin Liver Dis 2005, 25:265-280.
22. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Gu X., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009, 360:2544-2555.
23. Metcalf J.V., Mitchison H.C., Palmer J.M., Jones D.E., Bassendine M.F., James O.F. Natural history of early primary biliary cirrhosis. Lancet 1996, 348:1399-1402.
24. Nishio A., Van de Water J., Leung P.S., Joplin R., Neuberger J.M., Lake J., et al. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology 1997, 25:1085-1089.
25. Matsumura S., Van De Water J., Leung P., Odin J.A., Yamamoto K., Gores G.J., et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology 2004, 39:1415-1422.
26. Salunga T.L., Cui Z.G., Shimoda S., Zheng H.C., Nomoto K., Kondo T., et al. Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 2007, 29:78-86.
27. Lleo A., Selmi C., Invernizzi P., Podda M., Coppel R.L., Mackay I.R., et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009, 49:871-879.
28. Lleo A., Selmi C., Invernizzi P., Podda M., Gershwin M.E. The consequences of apoptosis in autoimmunity. J Autoimmun 2008, 31:257-262.
29. Allina J., Stanca C.M., Garber J., Hu B., Sautes-Fridman C., Bach N., et al. Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun 2008, 30:238-245.
30. Kikuchi K., Lian Z.X., Yang G.X., Ansari A.A., Ikehara S., Kaplan M., et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005, 128:304-312.
31. Aoki C.A., Roifman C.M., Lian Z.X., Bowlus C.L., Norman G.L., Shoenfeld Y., et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 2006, 27:50-53.
32. Wakabayashi K., Lian Z.X., Moritoki Y., Lan R.Y., Tsuneyama K., Chuang Y.H., et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 2006, 44:1240-1249.
33. Hsu W., Zhang W., Tsuneyama K., Moritoki Y., Ridgway W.M., Ansari A.A., et al. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice. Hepatology 2009, 49:133-140.
34. Sharfe N., Dadi H.K., Shahar M., Roifman C.M. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 1997, 94:3168-3171.
35. Caudy A.A., Reddy S.T., Chatila T., Atkinson J.P., Verbsky J.W. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 2007, 119:482-487.
36. Fontenot J.D., Rasmussen J.P., Gavin M.A., Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005, 6:1142-1151.
37. Lan R.Y., Cheng C., Lian Z.X., Tsuneyama K., Yang G.X., Moritoki Y., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006, 43:729-737.
38. Longhi M.S., Meda F., Wang P., Samyn M., Mieli-Vergani G., Vergani D., et al. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology 2008, 47:581-591.
39. Lan R.Y., Salunga T.L., Tsuneyama K., Lian Z.X., Yang G.X., Hsu W., et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 2009, 32:43-51.
40. Padgett K.A., Lan R.Y., Leung P.C., Lleo A., Dawson K., Pfeiff J., et al. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun 2009, 32:246-253.
41. Ansari A.A., Gershwin M.E. Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose. J Autoimmun 2009, 33:165-169.
42. Whittingham S., Rowley M.J., Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 2008, 31:197-200.
43. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 2008, 30:105-107.